Citadel Advisors’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$548K Buy
18,751
+3,963
+27% +$109K ﹤0.01% 9627
2026
Q1
$326K Buy
+14,788
New +$369K ﹤0.01% 10296
2025
Q1
Sell
-1,017
Closed -$25K 14597
2024
Q4
$25K Buy
1,017
+360
+55% +$15.7K ﹤0.01% 13029
2024
Q3
$35.4K Buy
+657
New +$35.2K ﹤0.01% 12278
2023
Q2
Sell
-1,464
Closed -$74K 14435
2023
Q1
$74K Buy
+1,464
New +$86.5K ﹤0.01% 11661
2021
Q3
Sell
-740
Closed -$229K 13868
2021
Q2
$229K Buy
+740
New +$231K ﹤0.01% 11863

Other funds holding CNBS

Citadel Advisors's CNBS Position: Q2 2026 in Review

Citadel Advisors increased its Amplify Seymour Cannabis ETF (CNBS) stake by 27% in Q2 2026, buying an estimated $109K and bringing the position to 18,751 shares worth $548K. The position accounts for ﹤0.01% of the portfolio, ranked #9627.

Citadel Advisors first reported a position in CNBS in Q2 2021 and has held it in 6 quarters since. 16 funds tracked by Wall St. Rank hold CNBS as of Q2 2026.

  • Citadel Advisors held 18,751 shares of Amplify Seymour Cannabis ETF worth $548K as of Q2 2026.
  • Citadel Advisors bought 3,963 Amplify Seymour Cannabis ETF shares in Q2 2026, an estimated $109K.
  • Amplify Seymour Cannabis ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #9627 holding.
  • Citadel Advisors first reported a position in Amplify Seymour Cannabis ETF in Q2 2021 and has held it in 6 quarters since.
  • 16 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.